Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna.. That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems where …
Read More »
Text size Maddie Meyer / Getty Images Moderna on Thursday lost a patent case that had been almost entirely overlooked as the stock increased due to excitement over the company’s Covid-19 vaccine, which will be tested in a large Phase 3 trial to begin. next week. What the decision issued …
Read More »
Text size Jason Alden / Bloomberg Data on the Covid-19 vaccine in development by AstraZeneca and the University of Oxford published in The Lancet on Monday looked positive, but the stock fell after rising last week due to high expectations for the data. Shares of the US deposit receipt for …
Read More »
At least two experimental COVID-19 vaccines produced a T-cell response in participants in early-stage clinical trials, which may indicate a longer-lasting form of immunity than an antibody response. BioNTech BNTX, + 3.46% and Pfizer Inc. PFE, + 0.69% It said early Monday morning that an ongoing early-stage clinical trial for …
Read More »
Prince William, Duke of Cambridge, wears a face mask as a precaution against the spread of COVID-19 and speaks to a patient participating in a COVID-19 vaccine trial at the Oxford Vaccine Group facility in Oxford, England, June 24, 2020. Steve Parsons / Agence France-Presse / Getty Images AstraZeneca and …
Read More »